ロード中...
Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
Breast cancer research has paved the way of personalized oncology with the introduction of hormonal therapy and the measurement of estrogen receptor as the first widely accepted clinical biomarker. The expression of another receptor—HER2/ERBB2/neu—was initially a sign of worse prognosis, but targete...
保存先:
| 出版年: | Microarrays (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003464/ https://ncbi.nlm.nih.gov/pubmed/27605190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microarrays2030228 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|